Simulations Plus, Inc.(NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has received a purchase order from the U.S. National Institutes of Health to renew its licenses for the Company’s best-in-class ClassPharmer™ software.

Ron Creeley, vice president of marketing and sales for Simulations Plus, said: “This renewal for ClassPharmer licenses testifies to the utility the Chemical Genomics unit at the NIH has found using this unique software in its research efforts. Our licenses to government agencies, which include the National Institutes of Health, National Cancer Institute, Environmental Protection Agency, and Food and Drug Administration in the U.S., as well as the Japanese equivalents of the EPA and FDA, are an important part of our business, as these agencies are seen as centers of excellence in their respective areas of research. Their selection of tools sets an example for other organizations that do similar research.”